{"entity":{"type":"insider","cik":"0001616905","url":"/insider/0001616905","json_url":"/insider/0001616905.json","name":"Fell Donald G.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":7,"first":"2020-12-15","last":"2025-06-10","span_basis":"filed_date"},"name_variants":[{"name":"Fell Donald G.","source":"filing","n_filings":7,"first_seen":"2020-12-15","last_seen":"2025-06-10"}],"transactions":[{"id":9294005,"accession":"0001641172-25-014569","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001641172-25-014569","line_url":"/filing/0001641172-25-014569#line-2","is_derivative":false,"issuer_cik":"0001616905","issuer_name":"Aspire Biopharma Holdings, Inc.","issuer_ticker":"ASBP","issuer_name_source":null,"issuer_url":"/issuer/0001616905","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10500.0,"shares_display":"10,500","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":4095.0,"total_display":"4,095.00","total_whole":"4,095","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-05","filed_date":"2025-06-10","scope":"insider"},{"id":4437182,"accession":"0001641172-25-014102","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001641172-25-014102","line_url":"/filing/0001641172-25-014102#line-2","is_derivative":false,"issuer_cik":"0001616905","issuer_name":"Aspire Biopharma Holdings, Inc.","issuer_ticker":"ASBP","issuer_name_source":null,"issuer_url":"/issuer/0001616905","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10500.0,"shares_display":"10,500","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":4095.0,"total_display":"4,095.00","total_whole":"4,095","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-05","filed_date":"2025-06-06","scope":"insider"},{"id":9294004,"accession":"0001641172-25-014569","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-014569","line_url":"/filing/0001641172-25-014569#line-1","is_derivative":false,"issuer_cik":"0001616905","issuer_name":"Aspire Biopharma Holdings, Inc.","issuer_ticker":"ASBP","issuer_name_source":null,"issuer_url":"/issuer/0001616905","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9500.0,"shares_display":"9,500","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":3705.0,"total_display":"3,705.00","total_whole":"3,705","shares_owned_after":9500.0,"shares_owned_after_display":"9,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-04","filed_date":"2025-06-10","scope":"insider"},{"id":4437178,"accession":"0001641172-25-014102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-014102","line_url":"/filing/0001641172-25-014102#line-1","is_derivative":false,"issuer_cik":"0001616905","issuer_name":"Aspire Biopharma Holdings, Inc.","issuer_ticker":"ASBP","issuer_name_source":null,"issuer_url":"/issuer/0001616905","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9500.0,"shares_display":"9,500","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":3705.0,"total_display":"3,705.00","total_whole":"3,705","shares_owned_after":9500.0,"shares_owned_after_display":"9,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-04","filed_date":"2025-06-06","scope":"insider"},{"id":6820891,"accession":"0001493152-22-024282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-024282","line_url":"/filing/0001493152-22-024282#line-1","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRxADE HEALTH, INC","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":1620.0,"total_display":"1,620.00","total_whole":"1,620","shares_owned_after":21139.0,"shares_owned_after_display":"21,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-25","filed_date":"2022-08-29","scope":"insider"},{"id":6427958,"accession":"0001493152-22-014319","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-014319","line_url":"/filing/0001493152-22-014319#line-1","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRxADE HEALTH, INC","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.26,"price_display":"1.26","price_state":"stated","total_value":2520.0,"total_display":"2,520.00","total_whole":"2,520","shares_owned_after":19639.0,"shares_owned_after_display":"19,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-18","scope":"insider"},{"id":9290099,"accession":"0001493152-21-008892","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-008892","line_url":"/filing/0001493152-21-008892#line-1","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRXADE GROUP, INC.","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.3,"price_display":"5.30","price_state":"stated","total_value":2650.0,"total_display":"2,650.00","total_whole":"2,650","shares_owned_after":9468.0,"shares_owned_after_display":"9,468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2021-04-15","scope":"insider"},{"id":2990884,"accession":"0001493152-20-023707","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-023707","line_url":"/filing/0001493152-20-023707#line-1","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRXADE GROUP, INC.","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.3,"price_display":"5.30","price_state":"stated","total_value":2650.0,"total_display":"2,650.00","total_whole":"2,650","shares_owned_after":8487.0,"shares_owned_after_display":"8,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-15","scope":"insider"},{"id":4723918,"accession":"0001493152-21-008889","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001493152-21-008889","line_url":"/filing/0001493152-21-008889#line-19","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRXADE GROUP, INC.","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":1000.0,"total_display":"1,000.00","total_whole":"1,000","shares_owned_after":1581.0,"shares_owned_after_display":"1,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-08","filed_date":"2021-04-15","scope":"insider"},{"id":4723901,"accession":"0001493152-21-008889","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001493152-21-008889","line_url":"/filing/0001493152-21-008889#line-14","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRXADE GROUP, INC.","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.55,"price_display":"0.55","price_state":"stated","total_value":550.0,"total_display":"550.00","total_whole":"550","shares_owned_after":3281.0,"shares_owned_after_display":"3,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-05","filed_date":"2021-04-15","scope":"insider"},{"id":4723892,"accession":"0001493152-21-008889","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001493152-21-008889","line_url":"/filing/0001493152-21-008889#line-11","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRXADE GROUP, INC.","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.62,"price_display":"0.62","price_state":"stated","total_value":124.0,"total_display":"124.00","total_whole":"124","shares_owned_after":4281.0,"shares_owned_after_display":"4,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-02","filed_date":"2021-04-15","scope":"insider"},{"id":4723890,"accession":"0001493152-21-008889","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001493152-21-008889","line_url":"/filing/0001493152-21-008889#line-10","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRXADE GROUP, INC.","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.54,"price_display":"0.54","price_state":"stated","total_value":540.0,"total_display":"540.00","total_whole":"540","shares_owned_after":4081.0,"shares_owned_after_display":"4,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-11","filed_date":"2021-04-15","scope":"insider"},{"id":4723883,"accession":"0001493152-21-008889","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001493152-21-008889","line_url":"/filing/0001493152-21-008889#line-8","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRXADE GROUP, INC.","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.55,"price_display":"0.55","price_state":"stated","total_value":1100.0,"total_display":"1,100.00","total_whole":"1,100","shares_owned_after":3781.0,"shares_owned_after_display":"3,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2021-04-15","scope":"insider"},{"id":4723877,"accession":"0001493152-21-008889","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001493152-21-008889","line_url":"/filing/0001493152-21-008889#line-6","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRXADE GROUP, INC.","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3.0,"shares_display":"3","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":0.78,"total_display":"0.78","total_whole":"1","shares_owned_after":2481.0,"shares_owned_after_display":"2,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-20","filed_date":"2021-04-15","scope":"insider"},{"id":4723874,"accession":"0001493152-21-008889","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001493152-21-008889","line_url":"/filing/0001493152-21-008889#line-5","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRXADE GROUP, INC.","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":148.0,"total_display":"148.00","total_whole":"148","shares_owned_after":2478.0,"shares_owned_after_display":"2,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-24","filed_date":"2021-04-15","scope":"insider"},{"id":4723869,"accession":"0001493152-21-008889","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001493152-21-008889","line_url":"/filing/0001493152-21-008889#line-4","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRXADE GROUP, INC.","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":0.44,"price_display":"0.44","price_state":"stated","total_value":352.0,"total_display":"352.00","total_whole":"352","shares_owned_after":2078.0,"shares_owned_after_display":"2,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-20","filed_date":"2021-04-15","scope":"insider"},{"id":4723864,"accession":"0001493152-21-008889","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-21-008889","line_url":"/filing/0001493152-21-008889#line-3","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRXADE GROUP, INC.","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4.0,"shares_display":"4","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":1.0,"total_display":"1.00","total_whole":"1","shares_owned_after":1278.0,"shares_owned_after_display":"1,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-30","filed_date":"2021-04-15","scope":"insider"},{"id":4723859,"accession":"0001493152-21-008889","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-21-008889","line_url":"/filing/0001493152-21-008889#line-2","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRXADE GROUP, INC.","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":150.0,"total_display":"150.00","total_whole":"150","shares_owned_after":1274.0,"shares_owned_after_display":"1,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2021-04-15","scope":"insider"},{"id":4723853,"accession":"0001493152-21-008889","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-008889","line_url":"/filing/0001493152-21-008889#line-1","is_derivative":false,"issuer_cik":"0001382574","issuer_name":"TRXADE GROUP, INC.","issuer_ticker":"MEDS","issuer_name_source":null,"issuer_url":"/issuer/0001382574","owner_cik":"0001616905","owner_name":"Fell Donald G.","owner_display_name":"Fell Donald G.","owner_url":"/insider/0001616905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":0.42,"price_display":"0.42","price_state":"stated","total_value":210.0,"total_display":"210.00","total_whole":"210","shares_owned_after":774.0,"shares_owned_after_display":"774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-07","filed_date":"2021-04-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001847345","name":"Aspire Biopharma Holdings, Inc.","url":"/issuer/0001847345","role":"Director","n_filings":2,"first_seen":"2025-06-06","last_seen":"2025-06-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001382574","name":"TRxADE HEALTH, INC","url":"/issuer/0001382574","role":"Director","n_filings":5,"first_seen":"2020-12-15","last_seen":"2022-08-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001616905","retrieved_at":"2026-08-27T07:16:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}